BAX – Baxter International Inc. – Fundamental analysis, financial statements, key ratios, and fair value analysis

Baxter International Inc.

Healthcare
Medical Instruments & Supplies
66.5
2.02
3.13%
77.8
61.45
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)2.18
EPS Estimate Currrent Qtr0.72
Book Value Per Share17.16
Market Cap 35 Billion
PE Ratio 29
Dividend Yield1.1850928

Stock Yield

Stock Return 7 Days6.12%
Stock Return 15 Days1.59%
Stock Return 30 Days -5.77%
Stock Return 3 Months-15.64%
Stock Return One Year-2.68%
Stock Return 3 Years-1.77%

Stock Technical Analysis

Relative Strengh Index (14)41.15
Average True Range (14)1.72
Momentum (14)-2.52
Simple Moving Average (14) -2.52
Time Series Forecast (14)63.63
Time Series Forecast (30) 67.83

Stock News

NewsSourcePublished
GE’s Healthcare Unit Spin-Off to Enhance Shareholder WealthYahoo Finance01/04/2019 12:31
Can Baxter (BAX) Keep the Earnings Surprise Streak Alive?Yahoo Finance01/03/2019 15:10
Morgan Stanley Finds A Few Reasons To Double Upgrade BaxterYahoo Finance01/02/2019 19:34
Read This Before Buying Baxter International Inc. (NYSE:BAX) For Its DividendYahoo Finance01/02/2019 11:04
6 Undervalued Stocks Growing EarningsYahoo Finance12/31/2018 20:11
Mallinckrodt’s Inhaled Xenon Gas Therapy Enters Phase IIIYahoo Finance12/24/2018 14:29
Baxter to Host Fourth Quarter 2018 Financial Results Conference Call for InvestorsYahoo Finance12/21/2018 21:15
4 Stocks Respected Activist Investor Jeffrey Smith Bought in Q3 (and 1 He Dumped)Yahoo Finance12/20/2018 14:27
New Research: Key Drivers of Growth for Baxter International, Sempra Energy, Nielsen Holdings Plc, ARRIS International plc, Ionis Pharmaceuticals, and KB Home — Factors of Influence, Major Initiatives and Sustained ProductionYahoo Finance12/20/2018 12:20
Credit Suisse Initiates Coverage of Large Health Care StocksYahoo Finance12/19/2018 19:46
Stock Market News For Dec 19, 2018Yahoo Finance12/19/2018 14:30
Baxter launches curved applicator for FlosealSeeking Alpha12/18/2018 08:49
Baxter Launches Curved Applicator for Floseal, Expanding Use of Leading Hemostat During ENT ProceduresYahoo Finance12/18/2018 13:30
Credit Suisse sees 18% upside in Abbott in premarket analyst actionSeeking Alpha12/18/2018 08:05
At US$65.70, Is It Time To Put Baxter International Inc. (NYSE:BAX) On Your Watch List?Yahoo Finance12/16/2018 13:35

Financial Statements

index2014201520162017
Revenue11 Billion10 Billion10 Billion11 Billion
Cost of Revenue6 Billion6 Billion6 Billion6 Billion
Gross Profit5 Billion4 Billion4 Billion4 Billion
Gross Margin (%)42.74%41.59%40.44%42.25%
Selling General and Administrative Expense3 Billion3 Billion3 Billion3 Billion
Other operating expenses-1 Billion-77 Million-4 Billion610 Million
Earning Before Interest and Taxes EBIT3 Billion1 Billion5 Billion1 Billion
EBIT/Operating Margin (%)24.96%11.33%49.39%11.98%
Interest Expense145 Million126 Million66 Million55 Million
Other non-operating expenses/income0000
Earnings before Tax3 Billion1 Billion5 Billion1 Billion
Income Tax Expense33 Million35 Million-12 Million493 Million
Net Income2 Billion968 Million5 Billion717 Million
Net Margin (%)23.30%9.71%48.85%6.79%
Earnings per share from operating income0.2349310.6626830.1121951.36767
Earnings per Diluted Share4.561.769.011.29
Dividends per Basic Common Share2.0534.2830.5050.61
Payout ratio2.224390.051337417.84162.11475
Weighted average number of shares outstanding548 Million550 Million551 Million556 Million
index2017 Q42018 Q12018 Q22018 Q3
Revenue3 Billion3 Billion3 Billion3 Billion
Cost of Revenue2 Billion2 Billion2 Billion2 Billion
Gross Profit1 Billion1 Billion1 Billion1 Billion
Gross Margin (%)41.89%41.61%43.60%44.67%
Selling General and Administrative Expense697 Million622 Million681 Million685 Million
Other operating expenses168 Million42 Million143 Million134 Million
Earning Before Interest and Taxes EBIT297 Million450 Million415 Million417 Million
EBIT/Operating Margin (%)10.71%16.81%14.60%15.07%
Interest Expense14 Million12 Million11 Million11 Million
Other non-operating expenses/income0000
Earnings before Tax283 Million438 Million404 Million406 Million
Income Tax Expense354 Million49 Million61 Million-138 Million
Net Income-71 Million389 Million343 Million544 Million
Net Margin (%)-0.00%14.53%12.07%19.66%
Earnings per share from operating income32.17771.629311.92050.766544
Earnings per Diluted Share-00.710.631
Dividends per Basic Common Share0.160.160.190.19
Payout ratio-14.43753.315795.26316
Weighted average number of shares outstanding546 Million548 Million544 Million544 Million
index2014201520162017
Cash and Equivalents3 Billion2 Billion3 Billion3 Billion
Trade and Non Trade Receivables2 Billion2 Billion2 Billion2 Billion
Inventory2 Billion2 Billion1 Billion1 Billion
Other current assets10 Billion11 Billion6 Billion7 Billion
Current Assets10 Billion12 Billion7 Billion7 Billion
Total Non-Current Assets16 Billion9 Billion9 Billion10 Billion
Total Assets26 Billion21 Billion16 Billion17 Billion
Trade and Non Trade Payables3 Billion3 Billion3 Billion3 Billion
Other current liabilities3 Billion3 Billion132 Million88 Million
Current Liabilities6 Billion6 Billion3 Billion3 Billion
Liabilities Non Current12 Billion6 Billion5 Billion5 Billion
Accumulated Retained Earnings Deficit13 Billion10 Billion14 Billion14 Billion
Shareholder’s equity other-5 Billion-837 Million-6 Billion-5 Billion
Shareholders Equity8 Billion9 Billion8 Billion9 Billion
Noncontrolling interests12 Billion12 Billion5 Billion6 Billion
Total Assets26 Billion21 Billion16 Billion17 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents3 Billion3 Billion3 Billion3 Billion
Trade and Non Trade Receivables2 Billion2 Billion2 Billion2 Billion
Inventory1 Billion2 Billion2 Billion2 Billion
Other current assets7 Billion7 Billion6 Billion6 Billion
Current Assets7 Billion7 Billion7 Billion7 Billion
Total Non-Current Assets10 Billion10 Billion10 Billion10 Billion
Total Assets17 Billion17 Billion17 Billion17 Billion
Trade and Non Trade Payables3 Billion3 Billion3 Billion3 Billion
Other current liabilities88 Million109 Million105 Million112 Million
Current Liabilities3 Billion3 Billion3 Billion3 Billion
Liabilities Non Current5 Billion5 Billion5 Billion5 Billion
Accumulated Retained Earnings Deficit14 Billion15 Billion15 Billion15 Billion
Shareholder’s equity other-5 Billion-6 Billion-6 Billion-6 Billion
Shareholders Equity9 Billion9 Billion9 Billion9 Billion
Noncontrolling interests6 Billion5 Billion5 Billion5 Billion
Total Assets17 Billion17 Billion17 Billion17 Billion
index2014201520162017
Net Cash Flow from Operations3 Billion2 Billion2 Billion2 Billion
Capital Expenditure-925 Million-911 Million-719 Million-634 Million
Net Cash Flow from Investing-2 Billion-2 Billion-715 Million-1 Billion
Net Cash Flow from Financing-1 Billion-481 Million-324 Million61 Million
Cash and Equivalents3 Billion2 Billion3 Billion3 Billion
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations514 Million447 Million405 Million489 Million
Capital Expenditure-224 Million-155 Million-156 Million-157 Million
Net Cash Flow from Investing-222 Million-374 Million-165 Million-176 Million
Net Cash Flow from Financing-330 Million-545 Million-263 Million-287 Million
Cash and Equivalents3 Billion3 Billion3 Billion3 Billion

Stock Price History

table